昕瑞再生

Biotech/Healthcare

Xinrui Regeneration develops and manufactures small-molecule therapeutics. The company focuses on new technologies for somatic cell reprogramming and regenerative medicine, developing small-molecule drugs designed to reverse tissue and organ fibrosis and enable in situ regeneration of functional…

Latest round: Pre Series A (2022)